Clinician Adoption of Genetic Testing for Drug Metabolizing Enzymes: Is Patient Safety The Low-Hanging Fruit of Personalized Medicine?

Harry Enchin. Clinician Adoption of Genetic Testing for Drug Metabolizing Enzymes: Is Patient Safety The Low-Hanging Fruit of Personalized Medicine?. In AMIA 2009, American Medical Informatics Association Annual Symposium, San Francisco, CA, USA, November 14-18, 2009. AMIA, 2009. [doi]

Abstract

Abstract is missing.